相似文献
1
Angiopoietins, abdominal aortic aneurysm and atherosclerosis.
Atherosclerosis. 2011 Feb;214(2):237-43. doi: 10.1016/j.atherosclerosis.2010.08.051. Epub 2010 Aug 19.
2
CXCL8 hyper-signaling in the aortic abdominal aneurysm.
Cytokine. 2018 Aug;108:96-104. doi: 10.1016/j.cyto.2018.03.031. Epub 2018 Mar 26.
3
Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases.
Front Immunol. 2021 Sep 23;12:731701. doi: 10.3389/fimmu.2021.731701. eCollection 2021.
4
Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
Cardiovasc Res. 2011 Jul 15;91(2):358-67. doi: 10.1093/cvr/cvr080. Epub 2011 Mar 24.
5
Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm.
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1400-9. doi: 10.1161/ATVBAHA.112.247866. Epub 2012 May 3.
6
The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm.
Int J Mol Sci. 2016 Aug 11;17(8):1312. doi: 10.3390/ijms17081312.
7
Macrophages.
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2509-19. doi: 10.1161/ATVBAHA.114.304794.
8
Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
Vascul Pharmacol. 2021 Feb;136:106818. doi: 10.1016/j.vph.2020.106818. Epub 2020 Nov 21.
9
RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm.
J Magn Reson Imaging. 2017 Apr;45(4):1144-1153. doi: 10.1002/jmri.25459. Epub 2016 Sep 30.
10
A diet enriched with tree nuts reduces severity of atherosclerosis but not abdominal aneurysm in angiotensin II-infused apolipoprotein E deficient mice.
Atherosclerosis. 2018 Oct;277:28-33. doi: 10.1016/j.atherosclerosis.2018.08.004. Epub 2018 Aug 17.
引用本文的文献
1
Iron Overload and Abdominal Aortic Aneurysm.
Rev Cardiovasc Med. 2024 Oct 9;25(10):361. doi: 10.31083/j.rcm2510361. eCollection 2024 Oct.
2
Targeting the smooth muscle cell Keap1-Nrf2-GSDMD-pyroptosis axis by cryptotanshinone prevents abdominal aortic aneurysm formation.
Theranostics. 2024 Oct 7;14(17):6516-6542. doi: 10.7150/thno.98400. eCollection 2024.
3
Comparative Analysis of Circular RNAs Expression and Function between Aortic and Intracranial Aneurysms.
Curr Drug Targets. 2024;25(13):866-884. doi: 10.2174/0113894501319306240819052840.
4
Deciphering the circulating immunological landscape of thoracic aortic aneurysm: Insights from a two-sample Mendelian randomization study.
Heliyon. 2024 May 15;10(10):e31198. doi: 10.1016/j.heliyon.2024.e31198. eCollection 2024 May 30.
5
Transcriptomic analysis identifies the shared diagnostic biomarkers and immune relationship between Atherosclerosis and abdominal aortic aneurysm based on fatty acid metabolism gene set.
Front Mol Biosci. 2024 Apr 10;11:1365447. doi: 10.3389/fmolb.2024.1365447. eCollection 2024.
6
Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relative risk factors-a mendelian randomization analysis.
Cardiovasc Diabetol. 2024 Feb 3;23(1):51. doi: 10.1186/s12933-024-02140-2.
7
Clinical value of serum miR-1-3p as a potential circulating biomarker for abdominal aortic aneurysm.
Ann Med. 2023;55(2):2260395. doi: 10.1080/07853890.2023.2260395. Epub 2023 Sep 26.
8
Dysregulations of Key Regulators of Angiogenesis and Inflammation in Abdominal Aortic Aneurysm.
Int J Mol Sci. 2023 Jul 28;24(15):12087. doi: 10.3390/ijms241512087.
9
Molecular Mechanisms in Genetic Aortopathy-Signaling Pathways and Potential Interventions.
Int J Mol Sci. 2023 Jan 16;24(2):1795. doi: 10.3390/ijms24021795.
10
Lipoprotein (a) Levels and Abdominal Aortic Aneurysm. A Systematic Review and Meta-analysis.
Curr Pharm Des. 2022;28(43):3492-3499. doi: 10.2174/1381612829666221124110920.
本文引用的文献
1
Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1075-7. doi: 10.1161/ATVBAHA.110.206573.
2
Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.
Mol Cell. 2010 Mar 12;37(5):643-55. doi: 10.1016/j.molcel.2010.02.007.
3
Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
Cell Signal. 2010 Mar;22(3):527-32. doi: 10.1016/j.cellsig.2009.11.007.
4
Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms.
Growth Factors. 2009 Dec;27(6):335-44. doi: 10.3109/08977190903155043.
5
Understanding abdominal aortic aneurysm.
N Engl J Med. 2009 Sep 10;361(11):1114-6. doi: 10.1056/NEJMcibr0905244.
6
Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients' management.
Curr Opin Cardiol. 2009 Nov;24(6):532-8. doi: 10.1097/HCO.0b013e328330c2d3.
7
Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide.
Circ Res. 2009 Jun 19;104(12):1333-6. doi: 10.1161/CIRCRESAHA.109.196154. Epub 2009 May 21.
8
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
J Hypertens. 2009 Aug;27(8):1641-7. doi: 10.1097/HJH.0b013e32832be575.
9
Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Cell Signal. 2009 Aug;21(8):1346-50. doi: 10.1016/j.cellsig.2009.04.002. Epub 2009 Apr 17.
10
Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation.
Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1329-35. doi: 10.1152/ajpheart.01341.2008. Epub 2009 Mar 20.
Zotero 插件